A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer|Other Solid Tumors
Interventions: DRUG: Comparator: MK0752, Notch Inhibitor|DRUG: Comparator: MK0752, Notch Inhibitor - 450 mg|DRUG: Comparator: MK0752, Notch Inhibitor - 3 days on, 4 off|DRUG: Comparator: MK0752, Notch Inhibitor - 1 day on, 6 off|DRUG: Comparator: MK0752, Notch Inhibitor - 3 days on, 4 off 350 mg
Sponsor: Merck Sharp & Dohme LLC